The CF AMR Syndicate and the NIHR Newcastle Invitro Diagnostic cooperative have produced a target product profile (TPP) guidance document to help drive the development of diagnostics for cystic fibrosis (CF) lung infections and invite you to contribute your insights on this document via a survey.
The CF AMR Syndicate wants to hear from a diverse group of stakeholders covering the clinic, academia, industry, including people living with CF who can help identify any additional key considerations that should be incorporated in the document.
Your insights will be instrumental in advancing diagnostics for CF lung infections and ensuring new diagnostics developed align with the current and future needs of people living with CF. To participate, please use this link.
The survey will close at 23.45 (BST) on 16 October.